• Home
  • Ultratech India Limited
  • Solifenacin Succinate, Ibandronate Sodium, Sodium Alendronate, Zoledronic Acid, Brinzolamide, Dorzolamide HCl, DOTA (Tetraxetan), Gadobutrol and Gadoterate Meglumine.

Solifenacin Succinate, Ibandronate Sodium, Sodium Alendronate, Zoledronic Acid, Brinzolamide, Dorzolamide HCl, DOTA (Tetraxetan), Gadobutrol and Gadoterate Meglumine.

  • Solifenacin Succinate, Ibandronate Sodium, Sodium Alendronate, Zoledronic Acid, Brinzolamide, Dorzolamide HCl, DOTA (Tetraxetan), Gadobutrol and Gadoterate Meglumine. 1
  • Solifenacin Succinate, Ibandronate Sodium, Sodium Alendronate, Zoledronic Acid, Brinzolamide, Dorzolamide HCl, DOTA (Tetraxetan), Gadobutrol and Gadoterate Meglumine. 2
Product Description

Ultratech India Limited is a 30 year old transnational company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and a diverse range of branded generic Finished Dosage Forms (FDFs) at its cGMP certified state-of-the-art manufacturing facilities in India, with a global presence.

We manufactures approximately 60 APIs and its key products are Trimetazidine, Fluconazole, Salbutamol, Glibenclamide, Vardenafil, Sildenafil, Tadalafil, Formoterol, Salmeterol, Ezetimibe, Oseltamivir, Bilastine, Vonoprazan, Nebivolol, Gadobutrol, Tetraxetan, Gadoterate, Dabigatran, Solifenacin, Vigabatrin, Dorzolamide, Valganciclovir, and Rivaroxaban, Vortioxetine, Voriconazole

Ultratech, with its base in India and Europe, delivers its products to global pharmaceutical markets, supported by comprehensive documentation including DMFs, CTD dossiers, FSCs, and COPPs, and holds registrations in Russia, the EU, Latin America, Brazil, and SEA.

Read more Show less

Ultratech India Limited

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Categories
more categories Show less
Specifications
  • Details
    Genito-urinary, Anti Osteoporosis, Anti Glaucoma, Chelating / MRI Contrast Agent

  • Selling Points
    Anti-Allergens; Bone & Joint Health; Cardiovascular Health; Digestive Health; International Approvals/Standards; Quality Service; The company's branded generic FDF portfolio includes over 300 drugs across a variety of therapeutic segments, including Cardiology, Diabetology, Antibiotics, Analgesics, Antineoplastics, Respiratory, Anti-Malarial, Gynaecology, Paediatrics, Nutraceuticals, and Health Supplements. Its FDFs product portfolio spans conventional dosage forms such as tablets, capsules, and injections, as well as advanced delivery systems like Pressurized Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs). 

     The company has state-of-the-art manufacturing infrastructure supported with a well-equipped R&D unit.

    The company also offers CDMO (Contract Development and Manufacturing Organization) services, custom synthesis for small molecule drug substances, process development, and contract manufacturing for both Bulk APIs and Pharmaceutical Finished Dosage Forms.


  • Model
    API
  • Supplied from
    India
  • Measured In
    kilogram
More specifications Fewer specifications
Sales Markets
Show more Show less

Ultratech India Limited

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
View company profile

More Products from Ultratech India Limited (75)

show all 75 other products

Ultratech India Limited resources (1)